{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:31:58Z","timestamp":1760488318051,"version":"build-2065373602"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360579"],"award-info":[{"award-number":["82360579"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Ten Thousand Person Plan Famous Doctor Special Project of Yunnan Province","award":["YunCaiXing [2020] 300\u20131803"],"award-info":[{"award-number":["YunCaiXing [2020] 300\u20131803"]}]},{"name":"the Science and Technology Innovation Team of Kunming Medical University","award":["CXTD202008"],"award-info":[{"award-number":["CXTD202008"]}]},{"name":"the Yunnan Provincial Science and Technology Department-Kunming Medical University Joint Project","award":["202401AY070001-053"],"award-info":[{"award-number":["202401AY070001-053"]}]},{"name":"the Second Affiliated Hospital of Kunming Medical University foreign cooperative research project","award":["2022dwhz06"],"award-info":[{"award-number":["2022dwhz06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03734-2","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:24:51Z","timestamp":1760448291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fedratinib inhibits ovarian cancer progression by downregulating QPCT expression"],"prefix":"10.1007","volume":"16","author":[{"given":"Ying","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongji","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"3734_CR1","doi-asserted-by":"crossref","unstructured":"Zhang Q, Madden NE, Wong AST. et.al. The role of endocrine G Protein-Coupled receptors in ovarian cancer progression. Frontiers in endocrinology,2017, 8:66.","DOI":"10.3389\/fendo.2017.00066"},{"key":"3734_CR2","doi-asserted-by":"crossref","unstructured":"Sung, Hyuna et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 2021, 71 (3): 209\u2013249.","DOI":"10.3322\/caac.21660"},{"key":"3734_CR3","volume-title":"NCCN clinical practice guidelines in Oncology-myeloproliferative neoplasms v3.2020","author":"National Comprehensive Cancer Network","year":"2019","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in Oncology-myeloproliferative neoplasms v3.2020. Fort Washington, PA, USA: National Comprehensive Cancer Network; 2019."},{"key":"3734_CR4","doi-asserted-by":"publisher","unstructured":"Apelian S, Martincuks A, Whittum M et al. PARP Inhibitors in Ovarian Cancer: Resistance Mechanisms, Clinical Evidence, and Evolving Strategies. Biomedicines. 2025 6;13(5):1126. https:\/\/doi.org\/10.3390\/biomedicines13051126","DOI":"10.3390\/biomedicines13051126"},{"key":"3734_CR5","volume-title":"INREBIC\u00ae (fedratinib) prescribing information","author":"Impact Biomedicines","year":"2019","unstructured":"Impact Biomedicines. INREBIC\u00ae (fedratinib) prescribing information. Summit, NJ: Impact Biomedicines, Inc; 2019."},{"issue":"1","key":"3734_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3892\/ijo.2021.5228","volume":"59","author":"T Zhao","year":"2021","unstructured":"Zhao T, Zhou Y, Wang Q, et al. QPCT regulation by CTCF leads to Sunitinib resistance in renal cell carcinoma by promoting angiogenesis. Int J Oncol. 2021;59(1):48. https:\/\/doi.org\/10.3892\/ijo.2021.5228.","journal-title":"Int J Oncol"},{"key":"3734_CR7","doi-asserted-by":"publisher","first-page":"154431","DOI":"10.1016\/j.prp.2023.154431","volume":"245","author":"T Liang","year":"2023","unstructured":"Liang T, Wu X, Wang L, Ni Z, Fan Y, Wu P, Wang H, Niu Y, Huang H. Clinical significance and diagnostic value of QPCT, SCEL and TNFRSF12A in papillary thyroid cancer. Pathol Res Pract. 2023;245:154431. https:\/\/doi.org\/10.1016\/j.prp.2023.154431.","journal-title":"Pathol Res Pract"},{"key":"3734_CR8","doi-asserted-by":"publisher","first-page":"e584","DOI":"10.7717\/peerj-cs.584","volume":"127","author":"J Li\u00f1ares-Blanco","year":"2021","unstructured":"Li\u00f1ares-Blanco J, Pazos A, Fernandez-Lozano C. Machine learning analysis of TCGA cancer data. PeerJ Comput Sci. 2021;127:e584.","journal-title":"PeerJ Comput Sci"},{"issue":"1","key":"3734_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1186\/s12884-025-07752-4","volume":"29","author":"Z Qu","year":"2025","unstructured":"Qu Z, Luo Z, Wang Y, et al. ITGB3 and associated molecules as critical biomarkers in Cesarean Scar pregnancy. BMC Pregnancy Childbirth. 2025;29(1):629. https:\/\/doi.org\/10.1186\/s12884-025-07752-4.","journal-title":"BMC Pregnancy Childbirth"},{"key":"3734_CR10","doi-asserted-by":"publisher","unstructured":"Yu H, Zou D, Ni N et al. Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway. J Ovarian Res 2022 19;15(1):98. https:\/\/doi.org\/10.1186\/s13048-022-01030-z","DOI":"10.1186\/s13048-022-01030-z"},{"issue":"3","key":"3734_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/omi.12335","volume":"36","author":"B Wang","year":"2021","unstructured":"Wang B, Bai S, Wang J, Ren N, et al. TPCA-1 negatively regulates inflammation mediated by NF- \u0138B pathway in mouse chronic periodontitis model. Mol Oral Microbiol. 2021;36(3):192\u2013201. https:\/\/doi.org\/10.1111\/omi.12335.","journal-title":"Mol Oral Microbiol"},{"issue":"10","key":"3734_CR12","doi-asserted-by":"publisher","first-page":"e14314","DOI":"10.1111\/jfbc.14314","volume":"46","author":"KE Duman","year":"2022","unstructured":"Duman KE, Dogan A, Kaptaner B. Ameliorative role of Cyanus depressus (M.Bieb.) Soj\u00e1k plant extract against diabetes-associated oxidative-stress-induced liver, kidney, and pancreas damage in rats. J Food Biochem. 2022;46(10):e14314. https:\/\/doi.org\/10.1111\/jfbc.14314.","journal-title":"J Food Biochem"},{"issue":"1","key":"3734_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.17305\/bb.2024.10397","volume":"25","author":"R Zhang","year":"2024","unstructured":"Zhang R, Wang Z, Wang H, et al. CTHRC1 is associated with BRAF(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma. Biomol Biomed. 2024;25(1):42\u201361. https:\/\/doi.org\/10.17305\/bb.2024.10397.","journal-title":"Biomol Biomed"},{"key":"3734_CR14","doi-asserted-by":"publisher","first-page":"963928","DOI":"10.3389\/fonc.2022.963928","volume":"12","author":"J Huo","year":"2022","unstructured":"Huo J, Shen Y, Zhang Y, et al. BI 2536 induces gasdermin E-dependent pyroptosis in ovarian cancer. Front Oncol. 2022;12:963928. https:\/\/doi.org\/10.3389\/fonc.2022.963928.","journal-title":"Front Oncol"},{"issue":"3","key":"3734_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.tranon.2018.11.016","volume":"12","author":"K Gorshkov","year":"2019","unstructured":"Gorshkov K, Sima N, Sun W, et al. Quantitative chemotherapeutic profiling of gynecologic cancer cell lines using approved drugs and bioactive compounds. Transl Oncol. 2019;12(3):441\u201352. https:\/\/doi.org\/10.1016\/j.tranon.2018.11.016.","journal-title":"Transl Oncol"},{"issue":"12","key":"3734_CR16","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.3390\/ijms26125661","volume":"26","author":"G Ewa","year":"2025","unstructured":"Ewa G, \u0141awicki P, Grabowska H, et al. Plasma concentrations of matrilysins (MMP-7, MMP-26) and stromelysins (MMP-3, MMP-10) as diagnostic biomarkers in High-Grade serous ovarian cancer patients. Int J Mol Sci. 2025;26(12):5661. https:\/\/doi.org\/10.3390\/ijms26125661.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3734_CR17","doi-asserted-by":"publisher","first-page":"e70020","DOI":"10.1111\/1759-7714.70020","volume":"16","author":"S Wei","year":"2025","unstructured":"Wei S, Guangyao Z, Xiangdong T, et al. Identifying lipid Metabolism-Related therapeutic targets and diagnostic markers for lung adenocarcinoma by Mendelian randomization and machine learning analysis. Thorac Cancer. 2025;16(6):e70020. https:\/\/doi.org\/10.1111\/1759-7714.70020.","journal-title":"Thorac Cancer"},{"issue":"3","key":"3734_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.55730\/1300-0152.2743","volume":"49","author":"B Cevatemre","year":"2025","unstructured":"Cevatemre B, I\u015fiklar A, Bulut \u0130, Karyemez E, et al. Butyrylcholinesterase (BChE) downregulation in taxane resistance: implications for prostate cancer. Turk J Biol. 2025;49(3):261\u201372. https:\/\/doi.org\/10.55730\/1300-0152.2743.","journal-title":"Turk J Biol"},{"key":"3734_CR19","doi-asserted-by":"crossref","unstructured":"Ye LF, Stockwell BR. Transforming Lipoxygenases: PE-Specific Enzymes in Disguise. Cell. 2017 19;171(3):501\u2013502.","DOI":"10.1016\/j.cell.2017.10.006"},{"issue":"10","key":"3734_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/toxins12100623","volume":"12","author":"JT Huang","year":"2020","unstructured":"Huang JT, Chang LC, Cheng CS, et al. Cytotoxicity produced by silicate nanoplatelets: study of cell death mechanisms. Toxins (Basel). 2020;12(10):623. https:\/\/doi.org\/10.3390\/toxins12100623.","journal-title":"Toxins (Basel)"},{"issue":"6","key":"3734_CR21","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1016\/j.apsb.2025.04.001","volume":"15","author":"B Liu","year":"2025","unstructured":"Liu B, Deng WZ, Hu WH, et al. Psychological stress-activated NR3C1\/NUPR1 axis promotes ovarian tumor metastasis. Acta Pharm Sin B. 2025;15(6):3149\u201362. https:\/\/doi.org\/10.1016\/j.apsb.2025.04.001.","journal-title":"Acta Pharm Sin B"},{"key":"3734_CR22","doi-asserted-by":"publisher","first-page":"1145487","DOI":"10.3389\/fmed.2023.1145487","volume":"10","author":"P Wu","year":"2023","unstructured":"Wu P, Jiang Q, Han L, et al. Systematic analysis and prediction for disease burden of ovarian cancer attributable to hyperglycemia: a comparative study between China and the world from 1990 to 2019. Front Med (Lausanne). 2023;10:1145487. https:\/\/doi.org\/10.3389\/fmed.2023.1145487.","journal-title":"Front Med (Lausanne)"},{"key":"3734_CR23","unstructured":"Jacobs MF, Murad AM, Cho ND, CDKN2A Cancer Predisposition. 2025 17. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132025."},{"issue":"1","key":"3734_CR24","doi-asserted-by":"publisher","first-page":"19231","DOI":"10.1038\/s41598-025-02329-9","volume":"15","author":"M Yano","year":"2025","unstructured":"Yano M, Katoh T, Miyazawa M, et al. Histone deacetylase 6 and programmed death ligand-1 expressions after neoadjuvant chemotherapy are upregulated in patients with ovarian high-grade serous carcinoma. Sci Rep. 2025;15(1):19231. https:\/\/doi.org\/10.1038\/s41598-025-02329-9.","journal-title":"Sci Rep"},{"issue":"5","key":"3734_CR25","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ajh.26857","volume":"98","author":"A Tefferi","year":"2023","unstructured":"Tefferi A, Primary myelofibrosis. 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98(5):801\u201321. 10.1002 \/ajh.26857.","journal-title":"Am J Hematol"},{"issue":"1","key":"3734_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, Bao Z, Lu J, Li L. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther. 2023;8(1):204. https:\/\/doi.org\/10.1038\/s41392-023-01468-7.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"3734_CR27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cell.2016.05.0698","volume":"166","author":"H Zhang","year":"2016","unstructured":"Zhang H, Liu T, Zhang Z, et al. Integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell. 2016;166(3):755\u201365. https:\/\/doi.org\/10.1016\/j.cell.2016.05.0698.","journal-title":"Cell"},{"issue":"5","key":"3734_CR28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5603\/GP.a2019.0045","volume":"90","author":"S Szubert","year":"2019","unstructured":"Szubert S, Moszynski R, Szpurek D, et al. The expression of platelet-derived growth factor receptors (PDGFRs) and their correlation with overall survival of patients with ovarian cancer. Ginekol Pol. 2019;90(5):242\u20139. https:\/\/doi.org\/10.5603\/GP.a2019.0045.","journal-title":"Ginekol Pol"},{"issue":"9","key":"3734_CR29","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1097\/IGC.0000000000000550","volume":"25","author":"Y Xu","year":"2015","unstructured":"Xu Y, Zhang J, Wu J, Zhong S, Li H. Inhibition of JAK2 reverses Paclitaxel resistance in human ovarian cancer cells. Int J Gynecol Cancer. 2015;25(9):1557\u201364. https:\/\/doi.org\/10.1097\/IGC.0000000000000550.","journal-title":"Int J Gynecol Cancer"},{"issue":"29","key":"3734_CR30","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1038\/s41388-018-0238-8","volume":"37","author":"W Zhou","year":"2018","unstructured":"Zhou W, Sun W, Yung MMH, et al. Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance. Oncogene. 2018;37(29):3981\u201397. https:\/\/doi.org\/10.1038\/s41388-018-0238-8.","journal-title":"Oncogene"},{"key":"3734_CR31","doi-asserted-by":"publisher","unstructured":"Zhao T, Bao Y, Gan X et al. DNA methylation-regulated QPCT promotes Sunitinib resistance by increasing HRAS stability in renal cell carcinoma. Theranostics 2019 14;9(21):6175\u201390. https:\/\/doi.org\/10.7150\/thno.35572","DOI":"10.7150\/thno.35572"},{"issue":"1","key":"3734_CR32","doi-asserted-by":"publisher","first-page":"2321767","DOI":"10.1080\/15384047.2024.2321767","volume":"25","author":"B Xu","year":"2024","unstructured":"Xu B, Yang L, Yang L, et al. Role of glutaminyl-peptide cyclotransferase in breast cancer doxorubicin sensitivity. Cancer Biol Ther. 2024;25(1):2321767. https:\/\/doi.org\/10.1080\/15384047.2024.2321767.","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"3734_CR33","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1021\/acschembio.7b00730","volume":"12","author":"R Shah","year":"2017","unstructured":"Shah R, Margison K, Pratt DA. The potency of diarylamine Radical-Trapping antioxidants as inhibitors of ferroptosis underscores the role of autoxidation in the mechanism of cell death. ACS Chem Biol. 2017;12(10):2538\u201345. https:\/\/doi.org\/10.1021\/acschembio.7b00730.","journal-title":"ACS Chem Biol"},{"issue":"2","key":"3734_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005;1(2):112\u20139. https:\/\/doi.org\/10.1038\/nchembio711.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"3734_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/bjh.18207","volume":"198","author":"CN Harrison","year":"2022","unstructured":"Harrison CN, Schaap N, Vannucchi AM, et al. Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase-2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts. Br J Haematol. 2022;198(2):317\u201327. https:\/\/doi.org\/10.1111\/bjh.18207.","journal-title":"Br J Haematol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03734-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03734-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03734-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T13:24:55Z","timestamp":1760448295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03734-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3734"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03734-2","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the The 2nd Affiliated Hospital of Kunming Medical University (No. Shen-PJ-Ke-2024-170 (\u5ba1-PJ-\u79d1-2024-170) ). All subjects consented to participate in the study and signed a consent form for participation in the study either in person or by agent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All subjects consented to the public release of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1865"}}